X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6930) 6930
Book Review (829) 829
Publication (490) 490
Conference Proceeding (18) 18
Dissertation (8) 8
Magazine Article (6) 6
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6717) 6717
deoxycytidine - analogs & derivatives (6520) 6520
index medicus (6444) 6444
female (5027) 5027
middle aged (4476) 4476
deoxycytidine - administration & dosage (4445) 4445
male (4282) 4282
aged (4197) 4197
oncology (4188) 4188
adult (3409) 3409
deoxycytidine - adverse effects (3335) 3335
antineoplastic combined chemotherapy protocols - therapeutic use (3312) 3312
chemotherapy (2879) 2879
gemcitabine (2524) 2524
antineoplastic combined chemotherapy protocols - adverse effects (2499) 2499
treatment outcome (2365) 2365
deoxycytidine - therapeutic use (2073) 2073
capecitabine (2061) 2061
cancer (2019) 2019
fluorouracil - analogs & derivatives (1975) 1975
fluorouracil - administration & dosage (1443) 1443
aged, 80 and over (1408) 1408
antimetabolites, antineoplastic - adverse effects (1268) 1268
drug administration schedule (1164) 1164
cisplatin (1129) 1129
therapy (1107) 1107
pancreatic neoplasms - drug therapy (1080) 1080
disease-free survival (1073) 1073
antimetabolites, antineoplastic - therapeutic use (1071) 1071
lung neoplasms - drug therapy (1032) 1032
cisplatin - administration & dosage (1015) 1015
care and treatment (1001) 1001
fluorouracil - adverse effects (999) 999
pharmacology & pharmacy (991) 991
neoplasm staging (989) 989
antimetabolites, antineoplastic - administration & dosage (935) 935
trial (926) 926
antineoplastic combined chemotherapy protocols - administration & dosage (912) 912
survival (861) 861
medicine & public health (851) 851
carcinoma, non-small-cell lung - drug therapy (845) 845
pancreatic cancer (837) 837
carcinoma (829) 829
survival analysis (823) 823
survival rate (802) 802
research (791) 791
adenocarcinoma - drug therapy (773) 773
breast neoplasms - drug therapy (769) 769
combination (764) 764
5-fluorouracil (657) 657
clinical trials (653) 653
dose-response relationship, drug (653) 653
organoplatinum compounds - administration & dosage (653) 653
retrospective studies (647) 647
pancreatic neoplasms - pathology (643) 643
drug therapy (629) 629
neoplasm metastasis (625) 625
antineoplastic agents (623) 623
paclitaxel (611) 611
antimitotic agents (594) 594
oxaliplatin (589) 589
metastasis (587) 587
fluorouracil - therapeutic use (584) 584
hematology, oncology and palliative medicine (569) 569
paclitaxel - administration & dosage (565) 565
disease progression (551) 551
fluorouracil (551) 551
adenocarcinoma (541) 541
prognosis (522) 522
toxicity (514) 514
docetaxel (510) 510
antineoplastic agents - therapeutic use (498) 498
kaplan-meier estimate (496) 496
analysis (485) 485
colorectal neoplasms - drug therapy (481) 481
combined modality therapy (479) 479
cancer research (472) 472
lung neoplasms - pathology (471) 471
radiotherapy (470) 470
phase-ii trial (459) 459
breast neoplasms - pathology (454) 454
pharmacology/toxicology (454) 454
phase-ii (449) 449
prospective studies (449) 449
taxoids - administration & dosage (447) 447
follow-up studies (443) 443
infusions, intravenous (435) 435
cisplatin - adverse effects (430) 430
tumors (419) 419
cell lung-cancer (417) 417
maximum tolerated dose (414) 414
antineoplastic agents - adverse effects (411) 411
dosage and administration (411) 411
time factors (409) 409
animals (407) 407
breast cancer (407) 407
health aspects (401) 401
bevacizumab (397) 397
carcinoma, non-small-cell lung - pathology (392) 392
carboplatin - administration & dosage (389) 389
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6481) 6481
Japanese (153) 153
Chinese (86) 86
French (70) 70
German (50) 50
Spanish (27) 27
Russian (19) 19
Italian (14) 14
Dutch (12) 12
Hungarian (8) 8
Polish (3) 3
Czech (2) 2
Danish (2) 2
Portuguese (2) 2
Bosnian (1) 1
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Lithuanian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Journal of Infectious Diseases, ISSN 0022-1899, 6/2011, Volume 203, Issue 12, pp. 1791 - 1801
Background. Long-term effects of abacavir (ABC)-lamivudine (3TC), compared with tenofovir (TDF)-emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus... 
HIV/AIDS | Percentage change | RNA | Spine | Bones | Bone density | Arm | Hip | Bone fractures | HIV 1 | Arts | INFECTIOUS DISEASES | EFFICACY | INITIATION | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | COMBINATION | OSTEOPOROSIS | HIV-INFECTED PATIENTS | WOMEN | THERAPY | COHORT | HEALTH | Humans | Middle Aged | Antiretroviral Therapy, Highly Active - adverse effects | Fractures, Bone - epidemiology | Male | Oligopeptides - adverse effects | Viral Load | Lamivudine - adverse effects | Tenofovir | Pyridines - adverse effects | Adenine - adverse effects | Ritonavir - adverse effects | Atazanavir Sulfate | Adult | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Drug Therapy, Combination | Emtricitabine | Adenine - analogs & derivatives | Osteoporosis - chemically induced | Anti-HIV Agents - adverse effects | Risk Factors | Organophosphonates - adverse effects | Benzoxazines - adverse effects | CD4 Lymphocyte Count | Absorptiometry, Photon | Bone Density - drug effects | HIV Infections - complications | Intention to Treat Analysis | HIV Infections - drug therapy | Fractures, Bone - chemically induced | Deoxycytidine - analogs & derivatives | Drug Combinations | Usage | Care and treatment | Ritonavir | Drug utilization | Lamivudine | Efavirenz | Prevention | Abacavir | Dosage and administration | Drug therapy, Combination | Drug therapy | HIV infection | Index Medicus | Abridged Index Medicus | Major and Brief Reports
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide... 
Internal Medicine | KIDNEY-DISEASE | RATES | MEDICINE, GENERAL & INTERNAL | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | SAFETY | ADULTS | ANTIRETROVIRAL THERAPY | LOPINAVIR/RITONAVIR | COUNT | EXPOSURE | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2014, Volume 14, Issue 7, pp. 581 - 589
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 18, pp. 1691 - 1703
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2016, Volume 34, Issue 25, pp. 2969 - 2979
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Summary Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected... 
Internal Medicine | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | COMBINATION THERAPY | GUIDELINES | PROTEASE-INHIBITOR | ANTIRETROVIRAL THERAPY | NEVIRAPINE | REGIMENS | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 1, pp. 64 - 71
Journal Article